Endocrine and Diabetes Biomarkers

A biomarker is any substance, structure, or process that should be measurable in the body or its products and it also influences or predicts the incidence of outcome or disease. For predicting type 1 diabetes, a biomarker should be present in a subset of the population, and this subset should have an influence on the proportion of people in whom this type 1 diabetes develops. A biomarker should also present a significant risk for the development of type 1 diabetes within a defined period of time or diagnose a “stage” in the progression to clinical or symptomatic type1 diabetes. As described in this article, most of the biomarkers are  used for the prediction of type 1 diabetes are islet-specific supporting the concept that, before overt hyperglycaemia, type 1 diabetes is generally predominantly a targeted disease rather than a systemic disease.

Atomic Biomarkers can be separated as a trademark that is precisely measured and gaged as a pointer of typical natural methods, pathogenic methodology, or pharmacologic reactions to a pharmaceutical intercession.

Biomarkers have fundamental influences in driving clinical trials and treating the patients. Progress in sub-atomic diagnostics helps medicinal experts make proficient, experimentally legitimate choices. All the more efficient disclosure and use of biomarkers in the development of ant diabetes medications will rely on upon quickening our comprehension of the pathogenesis of diabetes and particularly its macro vascular entanglements. Procedural upgrades in different fields, particularly tumour, are started to demonstrate the way towards the better models of diabetes pathogenesis and atomic biomarker revelation.

 

  • Prognostic marker
  • Diabetic nephropathy marker
  • Molecular marker for metabolic syndrome
  • Molecular Marker-Hypoglycaemic response
  • Inflammatory markers: Type 2 diabetes

Related Conference of Endocrine and Diabetes Biomarkers

September 20-21, 2019

15th World Congress on Endocrinology & Diabetes

| Prague, Czech Republic
September 20-21, 2019 |

Euro Diabetes Congress & Expo

Prague, Czech Republic
November 11-12, 2019

Annual Congress on Diabetes, Metabolism and Obesity

Sydney, Australia
December 02-03, 2019

14th European Diabetes and Endocrinology Congress

| Barcelona, Spain
Diabetes Congress 2019 | December 04-05, 2019 |

3rd Annual Congress on Diabetes and Its Complications

Tokyo, Japan
December 12-13, 2019

Annual Congress on Diabetes and Endocrinology

Dubai, UAE
January 29-30, 2020

Global Summit On Diabetes & Endocrinology

| Holiday Inn Atrium | Singapore
March 25-26, 2020

29th World Diabetes & Heart Congress

| Radisson Narita | Tokyo, Japan
March 27-28, 2020

Annual Summit on Metabolomics

Amsterdam, Netherlands
April 20-21, 2020

2nd Global Meeting on Diabetes and Endocrinology

Amsterdam, Netherlands
June 14-15, 2021

diabetic 2021

Abu Dhabi, UAE

Endocrine and Diabetes Biomarkers Conference Speakers

Recommended Sessions

Related Journals

Are you interested in